Infosys Limited vs Quick Heal Technologies Limited
A side-by-side comparison of Infosys Limited (INFY) and Quick Heal Technologies Limited (QUICKHEAL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Infosys Limited leads INFY vs QUICKHEAL on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability40
- Growth10
- Size & financial health31
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
INFY takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
INFY takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
INFY takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 30.8%", "Company has been maintaining a healthy dividend payout of 66.1%", "Company is almost debt free."]
- − ["Stock is trading at 5.08 times its book value"]
- + ["Company is almost debt free."]
- − ["The company has delivered a poor sales growth of -4.8% over past five years.", "Company has a low return on equity of 1.4% over last 3 years.", "Company reported a net loss of ₹11 Cr in its latest financial year."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.